These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 19223474)
1. Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytes. Negri DR; Pinto D; Vendetti S; Patrizio M; Sanchez M; Riccomi A; Ruggiero P; Del Giudice G; De Magistris MT Infect Immun; 2009 May; 77(5):1924-35. PubMed ID: 19223474 [TBL] [Abstract][Full Text] [Related]
2. Differential binding of Escherichia coli enterotoxins LT-IIa and LT-IIb and of cholera toxin elicits differences in apoptosis, proliferation, and activation of lymphoid cells. Arce S; Nawar HF; Russell MW; Connell TD Infect Immun; 2005 May; 73(5):2718-27. PubMed ID: 15845474 [TBL] [Abstract][Full Text] [Related]
4. Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells. Martin M; Hajishengallis G; Metzger DJ; Michalek SM; Connell TD; Russell MW Infect Immun; 2001 Jan; 69(1):252-61. PubMed ID: 11119513 [TBL] [Abstract][Full Text] [Related]
5. Cholera toxin and heat-labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cyclic AMP-dependent pathway. Bagley KC; Abdelwahab SF; Tuskan RG; Fouts TR; Lewis GK Infect Immun; 2002 Oct; 70(10):5533-9. PubMed ID: 12228279 [TBL] [Abstract][Full Text] [Related]
6. Distinct cytokine regulation by cholera toxin and type II heat-labile toxins involves differential regulation of CD40 ligand on CD4(+) T cells. Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW Infect Immun; 2001 Jul; 69(7):4486-92. PubMed ID: 11401990 [TBL] [Abstract][Full Text] [Related]
7. Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins. Zhao W; Zhao Z; Russell MW Mol Oral Microbiol; 2011 Jun; 26(3):200-9. PubMed ID: 21545697 [TBL] [Abstract][Full Text] [Related]
8. Role of B7 costimulatory molecules in the adjuvant activity of the heat-labile enterotoxin of Escherichia coli. Martin M; Sharpe A; Clements JD; Michalek SM J Immunol; 2002 Aug; 169(4):1744-52. PubMed ID: 12165495 [TBL] [Abstract][Full Text] [Related]
9. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants. Nawar HF; Arce S; Russell MW; Connell TD Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982 [TBL] [Abstract][Full Text] [Related]
10. Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity. Ryan EJ; McNeela E; Pizza M; Rappuoli R; O'Neill L; Mills KH J Immunol; 2000 Nov; 165(10):5750-9. PubMed ID: 11067933 [TBL] [Abstract][Full Text] [Related]
12. Enterotoxin adjuvants have direct effects on T cells and antigen-presenting cells that result in either interleukin-4-dependent or -independent immune responses. Yamamoto M; Kiyono H; Kweon MN; Yamamoto S; Fujihashi K; Kurazono H; Imaoka K; Bluethmann H; Takahashi I; Takeda Y; Azuma M; McGhee JR J Infect Dis; 2000 Jul; 182(1):180-90. PubMed ID: 10882596 [TBL] [Abstract][Full Text] [Related]
13. Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins. Connell TD Expert Rev Vaccines; 2007 Oct; 6(5):821-34. PubMed ID: 17931161 [TBL] [Abstract][Full Text] [Related]
14. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit. Boyaka PN; Ohmura M; Fujihashi K; Koga T; Yamamoto M; Kweon MN; Takeda Y; Jackson RJ; Kiyono H; Yuki Y; McGhee JR J Immunol; 2003 Jan; 170(1):454-62. PubMed ID: 12496431 [TBL] [Abstract][Full Text] [Related]
15. Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production. Brereton CF; Sutton CE; Ross PJ; Iwakura Y; Pizza M; Rappuoli R; Lavelle EC; Mills KH J Immunol; 2011 May; 186(10):5896-906. PubMed ID: 21490151 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of class II major histocompatibility complex antigen processing by Escherichia coli heat-labile enterotoxin requires an enzymatically active A subunit. Matousek MP; Nedrud JG; Cieplak W; Harding CV Infect Immun; 1998 Jul; 66(7):3480-4. PubMed ID: 9632629 [TBL] [Abstract][Full Text] [Related]
17. Genetically manipulated bacterial toxin as a new generation mucosal adjuvant. Yamamoto M; McGhee JR; Hagiwara Y; Otake S; Kiyono H Scand J Immunol; 2001 Mar; 53(3):211-7. PubMed ID: 11251876 [TBL] [Abstract][Full Text] [Related]
18. Enhanced antigen uptake by dendritic cells induced by the B pentamer of the type II heat-labile enterotoxin LT-IIa requires engagement of TLR2. Lee CH; Nawar HF; Mandell L; Liang S; Hajishengallis G; Connell TD Vaccine; 2010 May; 28(21):3696-705. PubMed ID: 20332049 [TBL] [Abstract][Full Text] [Related]
19. TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin. Lee CH; Masso-Welch P; Hajishengallis G; Connell TD J Leukoc Biol; 2011 Nov; 90(5):911-21. PubMed ID: 21791597 [TBL] [Abstract][Full Text] [Related]
20. Immunological relationships between cholera toxin and Escherichia coli heat-labile enterotoxin. Gilligan PH; Brown JC; Robertson DC Infect Immun; 1983 Nov; 42(2):683-91. PubMed ID: 6196292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]